Fig. 4

Cost-effectiveness acceptability curve for early medical intervention in dysmenorrhea and endometriosis from the perspective of healthcare payers. The results of a probabilistic analysis with 10,000-time Monte Carlo simulations are illustrated by cost-effectiveness acceptability curves and demonstrated the efficacy of medical intervention at a willingness to pay threshold of less than a million JPY per quality-adjusted life-year gained in more than 90% of the population